Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,328 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Concordance Between Recommendations From Multidisciplinary Molecular Tumor Boards and Central Consensus for Cancer Treatment in Japan.
Naito Y, Sunami K, Kage H, Komine K, Amano T, Imai M, Koyama T, Ennishi D, Kanai M, Kenmotsu H, Maeda T, Morita S, Sakai D, Watanabe K, Shirota H, Kinoshita I, Yoshioka M, Mamesaya N, Ito M, Kohsaka S, Saigusa Y, Yamamoto K, Hirata M, Tsuchihara K, Yoshino T. Naito Y, et al. Among authors: kanai m. JAMA Netw Open. 2022 Dec 1;5(12):e2245081. doi: 10.1001/jamanetworkopen.2022.45081. JAMA Netw Open. 2022. PMID: 36469316 Free PMC article.
Clinical practice guidance for next-generation sequencing in cancer diagnosis and treatment (edition 2.1).
Naito Y, Aburatani H, Amano T, Baba E, Furukawa T, Hayashida T, Hiyama E, Ikeda S, Kanai M, Kato M, Kinoshita I, Kiyota N, Kohno T, Kohsaka S, Komine K, Matsumura I, Miura Y, Nakamura Y, Natsume A, Nishio K, Oda K, Oda N, Okita N, Oseto K, Sunami K, Takahashi H, Takeda M, Tashiro S, Toyooka S, Ueno H, Yachida S, Yoshino T, Tsuchihara K; Japanese Society of Medical Oncology; Japan Society of Clinical Oncology; Japanese Cancer Association. Naito Y, et al. Among authors: kanai m. Int J Clin Oncol. 2021 Feb;26(2):233-283. doi: 10.1007/s10147-020-01831-6. Epub 2020 Nov 29. Int J Clin Oncol. 2021. PMID: 33249514 Free PMC article.
Correction to: The initial assessment of expert panel performance in core hospitals for cancer genomic medicine in Japan.
Sunami K, Naito Y, Aimono E, Amano T, Ennishi D, Kage H, Kanai M, Komine K, Koyama T, Maeda T, Morita S, Sakai D, Kohsaka S, Tsuchihara K, Yoshino T. Sunami K, et al. Among authors: kanai m. Int J Clin Oncol. 2021 May;26(5):1007. doi: 10.1007/s10147-021-01897-w. Int J Clin Oncol. 2021. PMID: 33786712 Free PMC article. No abstract available.
Current status and issues related to secondary findings in the first public insurance covered tumor genomic profiling in Japan: multi-site questionnaire survey.
Minamoto A, Yamada T, Shimada S, Kinoshita I, Aoki Y, Oda K, Ueki A, Higashigawa S, Morikawa M, Sato Y, Hirasawa A, Ogawa M, Kondo T, Yoshioka M, Kanai M, Muto M, Kosugi S. Minamoto A, et al. Among authors: kanai m. J Hum Genet. 2022 Oct;67(10):557-563. doi: 10.1038/s10038-022-01028-x. Epub 2022 Mar 23. J Hum Genet. 2022. PMID: 35322199
Expert panel consensus recommendations on the use of circulating tumor DNA assays for patients with advanced solid tumors.
Imai M, Nakamura Y, Sunami K, Kage H, Komine K, Koyama T, Amano T, Ennishi D, Kanai M, Kenmotsu H, Maeda T, Morita S, Sakai D, Bando H, Makiyama A, Suzuki T, Hirata M, Kohsaka S, Tsuchihara K, Naito Y, Yoshino T. Imai M, et al. Among authors: kanai m. Cancer Sci. 2022 Nov;113(11):3646-3656. doi: 10.1111/cas.15504. Epub 2022 Sep 11. Cancer Sci. 2022. PMID: 35876224 Free PMC article. Review.
Randomized phase III study of gemcitabine, cisplatin plus S-1 versus gemcitabine, cisplatin for advanced biliary tract cancer (KHBO1401- MITSUBA).
Ioka T, Kanai M, Kobayashi S, Sakai D, Eguchi H, Baba H, Seo S, Taketomi A, Takayama T, Yamaue H, Takahashi M, Sho M, Kamei K, Fujimoto J, Toyoda M, Shimizu J, Goto T, Shindo Y, Yoshimura K, Hatano E, Nagano H; Kansai Hepatobiliary Oncology Group (KHBO). Ioka T, et al. Among authors: kanai m. J Hepatobiliary Pancreat Sci. 2023 Jan;30(1):102-110. doi: 10.1002/jhbp.1219. Epub 2022 Aug 9. J Hepatobiliary Pancreat Sci. 2023. PMID: 35900311 Free PMC article. Clinical Trial.
Chronological improvement in precision oncology implementation in Japan.
Sunami K, Naito Y, Komine K, Amano T, Ennishi D, Imai M, Kage H, Kanai M, Kenmotsu H, Koyama T, Maeda T, Morita S, Sakai D, Kohsaka S, Tsuchihara K, Saigusa Y, Yoshino T. Sunami K, et al. Among authors: kanai m. Cancer Sci. 2022 Nov;113(11):3995-4000. doi: 10.1111/cas.15517. Epub 2022 Sep 2. Cancer Sci. 2022. PMID: 35976133 Free PMC article.
Clinical outcomes of second‑line chemotherapy after gemcitabine and cisplatin plus S‑1 treatment for patients with advanced biliary tract cancer in the KHBO1401‑3A study.
Shindo Y, Nagano H, Kanai M, Kobayashi S, Wada H, Sakai D, Eguchi H, Baba H, Kamachi H, Takayama T, Ueno M, Takahashi M, Nakagami Y, Yoshimura K, Hatano E, Ioka T. Shindo Y, et al. Among authors: kanai m. Oncol Rep. 2023 Feb;49(2):41. doi: 10.3892/or.2023.8478. Epub 2023 Jan 12. Oncol Rep. 2023. PMID: 36633148 Free PMC article.
1,328 results